The Association of Biotechnology Led Enterprises (ABLE) successfully conducted the phase-2 of Biotechnology Industry Research Assistance Council (BIRAC) supported series of "Stimulating Bio-Entrepreneurs" talks at the TNAU, Coimbatore to inspire future entrepreneurs. The evening lecture sessions on September 2 and 3 were attended by 350 students and 30 faculty members.
BENZ Inc. will be presenting new products at this years AMB and IMTS tradeshows. Products on display will include the BENZ LinA push-type aggregate and the BENZ Solidfix quick change system.
Tomi Sawyer, Distinguished Scientist & Head of Peptide Drug Discovery & Innovative Technologies at Merck will keynote present at 2nd Protein-Protein Interaction Conference to be held on October 23-24, 2014 in Boston, MA by GTC.
Arthur Weiss, Ephraim P. Engleman Distinguished Professor at University of California San Francisco will give a keynote presentation on, "Controlling T Cell Receptor Signaling with Genetically Selective Kinase Inhibitors" at the 3rd Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston, MA) by GTCbio.
Scot Mente, Senior Principal Scientist, Neuroscience Chemistry at Pfizer Research will give a presentation on, "Structure-Guided Design of CNS-Active CK1d Preferring Ligands" at the 3rd Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston, MA) by GTCbio.
Juhi Juneja, Senior Research Investigator at Bristol-Myers Squibb to Speak at 2nd Protein-Protein Interaction Conference, October 23-24, 2014 in Boston, MA.
Mark Bunnage, Vice President, Head of Chemistry Biotherapeutics Research at Pfizer To Give a Keynote Presentation at the 3rd Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston, MA).
Biotage announces the launch of ACI™ (Accelerated Chromatographic Isolation), a new advance converting simple flash purification into a faster and more economical way to isolate pure compounds.
Ricardo Henriques, University College London, to Speak on Super-Resolution Microscopy at Cell Based Assay & Screening Technologies Conference, October 7-8, 2014 in Dublin, Ireland.
Jianxin Zhang, Deputy Director of Protein Characterization at Sanofi Pasteur, will give a presentation on, "Antigen-Antibody Interaction Analyzed by Hydrogen-Deuterium Exchange Mass Spectrometry" at the 2nd Protein-Protein Interaction Conference to be held on October 23-24, 2014 in Boston, MA by GTCbio.
Nathanael Gray, Professor, Biological Chemistry and Molecular Pharmacology, Dana Farber Cancer Institute, Harvard Medical School To Give a Featured Presentation at the 3rd Protein Kinases & Drug Design Conference (Oct 23-24, 2014 in Boston, MA).
Igor Kaltashov, Professor and Graduate Program Director of Chemistry at the University of Massachusetts-Amherst to Speak at Protein Expression, Purification & Characterization Conference, October 23-24, 2014 in Boston, MA.
Frank Pacholec, Vice President, R&D & Corporate Sustainability Officer at Stepan Co. to Give Keynote Presentation at 5th Biobased Chemicals Commercialization & Partnering Conference (September 18-19, 2014 in San Francisco, CA).
Panel Discussion on, "Strategic Partnerships" Features Executives from Dow, Akzonobel, and Genomatica at 5th Biobased Chemicals Commercialization & Partnering Conference (September 18-19, 2014 in San Francisco, CA).
Vasilis Ntziachristos, Helmholtz Zentrum München, to Give Keynote Address at Imaging in Drug Discovery Conference, October 7-8, 2014 in Dublin, Ireland.
Dale Steichen, AkzoNobel to Give Keynote Presentation at 5th Biobased Chemicals Commercialization & Partnering Conference (September 18-19, 2014 in San Francisco, CA).
William Baum, Executive Chairman and Chief Business Development Officer of Genomatica to Give Featured Presentation at 5th Biobased Chemicals Commercialization & Partnering Conference (Sep 18-19, 2014 in San Francisco, CA).
Markus Pompejus, Vice President of White Biotechnology Research at BASF will give a keynote presentation at the 5th Biobased Chemicals Commercialization & Partnering Conference to be held on Sep. 18-19, 2014 in San Francisco, CA.
AnaSpec Launches Industry's First FRET-based Assay for Measurement of Insulin Degrading Enzyme (IDE) Activity for inhibitor high throughput screening- the SensoLyte® 520 IDE Activity Assay Kit.
Aaron K Soto, Vice President of Research at Sutro Biopharma, to Give a Presentation titled, "Design and Manufacture of Homogeneous Best-in-Class Antibody Drug Conjugates and Bispecifics by Cell-Free Protein Expression" at the Protein Expression, Purification & Characterization Conference, October 23 & 24, 2014, in Boston, MA, by GTCbio.
James C. Errey, Associate Director at Heptares Therapeutics Limited to Give a Presentation titled, "From StaR® to Structure, it's as easy as ABC" at the Protein Expression, Purification & Characterization Conference, October 23 & 24, 2014, in Boston, MA.
Satisfied Users & 
Approved Press Releases
